Bausch Health Companies Inc is one of the Canada-based company that is developing, manufactures, and markets a range of branded & generic pharmaceuticals. These medical devices are over-the-counter products. It is primarily developing products in the therapeutic areas of eye health, gastroenterology, and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis, and other dermatoses. BHC stock price at https://www.webull.com/quote/nyse-bhc is offering a selection of aesthetic medical devices that address a variety of conditions.
This is including facial wrinkles, acne, pigmentation conditions, and laser hair removal, among others. The gastrointestinal (GI) segment is offering products that treat GI and hematologic conditions are including hepatic encephalopathy, irritable bowel syndrome with diarrhea, and ulcerative colitis, among others.
4 Positions in the 1st Quarter
BHC stock price during the first quarter.
- DVA 30-Year Financial Data
- The intrinsic value of DVA
- Peter Lynch Chart of DVA
Chou sold 68,000 shares of DaVita that is reducing the position 67.50% and the equity portfolio 2.97%. Shares averaged $78.69 during the first quarter. The Denver-based company is providing dialysis services in the U.S. GuruFocus is ranking profitability 9 out of 10 on several positive investing signs. This is including a high Piotroski F-score of 7, consistent revenue growth, and an operating margin. This is outperforming over 83% of global competitors.
- Bausch Health
The transaction has trimmed the position by just 3.71% despite that is reducing the equity portfolio 1.04%. Shares averaged $24.35 during the first quarter. The Quebec-based company is manufactured products for the dermatology, gastrointestinal, and ophthalmology markets. The BHC stock price company ranks are financial strength 2 out of 10 on several warning signs, that is included interest coverage and debt ratios underperforming over 95% of global competitors.
- JPMorgan Chase
This is reducing the position 22.59% and the equity portfolio 0.81%. Shares averaged $122.27 during the first quarter. The New York-based bank is operated four financial service businesses that are including consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management.
- Bank of America
This is reducing the position 35.24% and the equity portfolio 0.20%. Shares averaged $30.21 during the first quarter. The Charlotte, North Carolina-based bank is operated four business segments such as consumer banking, global wealth and investment management, global banking, and global markets. Bank of America’s financial strength ranks is 3 out of 10 on the heels of increasing long-term debt over the past three years. You can also check cvs stock at https://www.webull.com/quote/nyse-cvs .